ARTICLE | Finance
Centocor Inc.
December 18, 1995 8:00 AM UTC
Centocor Inc. last week halted its EPILOG trial of ReoPro in a Phase III all comers trial in angioplasty after an interim look revealed overwhelmingly positive data. (see BioCentury Extra, Dec. 15)....